Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 May-Jun;22(3):214-8.
doi: 10.1007/s002709900369.

Access-related venous stenoses and occlusions: treatment with percutaneous transluminal angioplasty and Dacron-covered stents

Affiliations

Access-related venous stenoses and occlusions: treatment with percutaneous transluminal angioplasty and Dacron-covered stents

A Farber et al. Cardiovasc Intervent Radiol. 1999 May-Jun.

Abstract

Purpose: To determine the effectiveness of using Dacron-covered stents to treat access-related venous stenoses and occlusions.

Methods: Twenty-two Dacron-covered stents were placed in 20 patients: in the basilic or axillary vein (n = 2), cephalic vein (n = 3), subclavian vein (n = 5), and at the venous anastomosis of the polytetrafluoroethylene (PTFE) implant graft (n = 10).

Results: Initial technical success was 100%. The cumulative primary and secondary patency rates were 57% and 83% at 6 months, 29% and 64% at 12 months, and 29% and 53% at 18 months. A statistically significant difference in the stent patency was revealed by comparing the patients with stents in the subclavian vein and patients with upper arm stents. The secondary patency rates of the upper arm stents were 73% after 6, 12, and 18 months.

Conclusions: Percutaneous placement of Dacron-covered stents is a safe and effective procedure for salvage of a dialysis fistula. First results are promising, with a tendency to prolongation of the time interval between reinterventions.

PubMed Disclaimer

Substances

LinkOut - more resources